330 related articles for article (PubMed ID: 29318974)
21. Inflammatory cytokine tumor necrosis factor α suppresses neuroprotective endogenous erythropoietin from astrocytes mediated by hypoxia-inducible factor-2α.
Nagaya Y; Aoyama M; Tamura T; Kakita H; Kato S; Hida H; Saitoh S; Asai K
Eur J Neurosci; 2014 Dec; 40(11):3620-6. PubMed ID: 25283246
[TBL] [Abstract][Full Text] [Related]
22. Erythropoietin inhibits HIF-1α expression via upregulation of PHD-2 transcription and translation in an in vitro model of hypoxia-ischemia.
Souvenir R; Flores JJ; Ostrowski RP; Manaenko A; Duris K; Tang J
Transl Stroke Res; 2014 Feb; 5(1):118-27. PubMed ID: 24323731
[TBL] [Abstract][Full Text] [Related]
23. Recovery of motor spontaneous activity after intranasal delivery of human recombinant erythropoietin in a focal brain hypoxia model induced by CoCl2 in rats.
Merelli A; Caltana L; Girimonti P; Ramos AJ; Lazarowski A; Brusco A
Neurotox Res; 2011 Aug; 20(2):182-92. PubMed ID: 21116766
[TBL] [Abstract][Full Text] [Related]
24. Therapeutic applications of chelating drugs in iron metabolic disorders of the brain and retina.
Shahandeh A; Bui BV; Finkelstein DI; Nguyen CTO
J Neurosci Res; 2020 Oct; 98(10):1889-1904. PubMed ID: 32643793
[TBL] [Abstract][Full Text] [Related]
25. Protection from oxidative stress-induced apoptosis in cortical neuronal cultures by iron chelators is associated with enhanced DNA binding of hypoxia-inducible factor-1 and ATF-1/CREB and increased expression of glycolytic enzymes, p21(waf1/cip1), and erythropoietin.
Zaman K; Ryu H; Hall D; O'Donovan K; Lin KI; Miller MP; Marquis JC; Baraban JM; Semenza GL; Ratan RR
J Neurosci; 1999 Nov; 19(22):9821-30. PubMed ID: 10559391
[TBL] [Abstract][Full Text] [Related]
26. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA
J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810
[TBL] [Abstract][Full Text] [Related]
27. Multifunctional activities of green tea catechins in neuroprotection. Modulation of cell survival genes, iron-dependent oxidative stress and PKC signaling pathway.
Mandel SA; Avramovich-Tirosh Y; Reznichenko L; Zheng H; Weinreb O; Amit T; Youdim MB
Neurosignals; 2005; 14(1-2):46-60. PubMed ID: 15956814
[TBL] [Abstract][Full Text] [Related]
28. Conservative iron chelation for neurodegenerative diseases such as Parkinson's disease and amyotrophic lateral sclerosis.
Devos D; Cabantchik ZI; Moreau C; Danel V; Mahoney-Sanchez L; Bouchaoui H; Gouel F; Rolland AS; Duce JA; Devedjian JC;
J Neural Transm (Vienna); 2020 Feb; 127(2):189-203. PubMed ID: 31912279
[TBL] [Abstract][Full Text] [Related]
29. Up-regulation of hypoxia-inducible factor (HIF)-1α and HIF-target genes in cortical neurons by the novel multifunctional iron chelator anti-Alzheimer drug, M30.
Avramovich-Tirosh Y; Bar-Am O; Amit T; Youdim MB; Weinreb O
Curr Alzheimer Res; 2010 Jun; 7(4):300-6. PubMed ID: 20043814
[TBL] [Abstract][Full Text] [Related]
30. Oxidative stress and neurodegeneration: the involvement of iron.
Carocci A; Catalano A; Sinicropi MS; Genchi G
Biometals; 2018 Oct; 31(5):715-735. PubMed ID: 30014355
[TBL] [Abstract][Full Text] [Related]
31. Novel bifunctional drugs targeting monoamine oxidase inhibition and iron chelation as an approach to neuroprotection in Parkinson's disease and other neurodegenerative diseases.
Youdim MB; Fridkin M; Zheng H
J Neural Transm (Vienna); 2004 Oct; 111(10-11):1455-71. PubMed ID: 15480846
[TBL] [Abstract][Full Text] [Related]
32. Erythropoietin is a paracrine mediator of ischemic tolerance in the brain: evidence from an in vitro model.
Ruscher K; Freyer D; Karsch M; Isaev N; Megow D; Sawitzki B; Priller J; Dirnagl U; Meisel A
J Neurosci; 2002 Dec; 22(23):10291-301. PubMed ID: 12451129
[TBL] [Abstract][Full Text] [Related]
33. Erythropoietin gene regulation depends on heme-dependent oxygen sensing and assembly of interacting transcription factors.
Huang LE; Ho V; Arany Z; Krainc D; Galson D; Tendler D; Livingston DM; Bunn HF
Kidney Int; 1997 Feb; 51(2):548-52. PubMed ID: 9027736
[TBL] [Abstract][Full Text] [Related]
34. Oxygen sensing, hypoxia-inducible factor-1 and the regulation of mammalian gene expression.
Ratcliffe PJ; O'Rourke JF; Maxwell PH; Pugh CW
J Exp Biol; 1998 Apr; 201(Pt 8):1153-62. PubMed ID: 9510527
[TBL] [Abstract][Full Text] [Related]
35. Erythropoietin and Nrf2: key factors in the neuroprotection provided by apo-lactoferrin.
Zakharova ET; Sokolov AV; Pavlichenko NN; Kostevich VA; Abdurasulova IN; Chechushkov AV; Voynova IV; Elizarova AY; Kolmakov NN; Bass MG; Semak IV; Budevich AI; Kozhin PM; Zenkov NK; Klimenko VM; Kirik OV; Korzhevskii DE; Menshchikova EB; Vasilyev VB
Biometals; 2018 Jun; 31(3):425-443. PubMed ID: 29748743
[TBL] [Abstract][Full Text] [Related]
36. Induction of endothelial PAS domain protein-1 by hypoxia: characterization and comparison with hypoxia-inducible factor-1alpha.
Wiesener MS; Turley H; Allen WE; Willam C; Eckardt KU; Talks KL; Wood SM; Gatter KC; Harris AL; Pugh CW; Ratcliffe PJ; Maxwell PH
Blood; 1998 Oct; 92(7):2260-8. PubMed ID: 9746763
[TBL] [Abstract][Full Text] [Related]
37. Flavonoids-induced accumulation of hypoxia-inducible factor (HIF)-1alpha/2alpha is mediated through chelation of iron.
Park SS; Bae I; Lee YJ
J Cell Biochem; 2008 Apr; 103(6):1989-98. PubMed ID: 17973296
[TBL] [Abstract][Full Text] [Related]
38. Neuroprotection by hypoxic preconditioning involves oxidative stress-mediated expression of hypoxia-inducible factor and erythropoietin.
Liu J; Narasimhan P; Yu F; Chan PH
Stroke; 2005 Jun; 36(6):1264-9. PubMed ID: 15890996
[TBL] [Abstract][Full Text] [Related]
39. Desferoxamine preconditioning protects against cerebral ischemia in rats by inducing expressions of hypoxia inducible factor 1 alpha and erythropoietin.
Li YX; Ding SJ; Xiao L; Guo W; Zhan Q
Neurosci Bull; 2008 Apr; 24(2):89-95. PubMed ID: 18369388
[TBL] [Abstract][Full Text] [Related]
40. A(1) and A(3) adenosine receptors inhibit LPS-induced hypoxia-inducible factor-1 accumulation in murine astrocytes.
Gessi S; Merighi S; Stefanelli A; Fazzi D; Varani K; Borea PA
Pharmacol Res; 2013 Oct; 76():157-70. PubMed ID: 23969284
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
